Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Free Cash Flow (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Free Cash Flow for 3 consecutive years, with -$3.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow rose 23.15% year-over-year to -$3.8 million, compared with a TTM value of -$14.2 million through Sep 2025, up 10.13%, and an annual FY2024 reading of -$16.0 million, down 55.63% over the prior year.
  • Free Cash Flow was -$3.8 million for Q3 2025 at SeaStar Medical Holding, down from -$3.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.3 million in Q3 2023 and bottomed at -$5.0 million in Q3 2024.
  • Average Free Cash Flow over 3 years is -$3.3 million, with a median of -$3.0 million recorded in 2025.
  • The sharpest move saw Free Cash Flow crashed 274.12% in 2024, then grew 23.91% in 2025.
  • Year by year, Free Cash Flow stood at -$4.5 million in 2023, then decreased by 4.64% to -$4.7 million in 2024, then increased by 18.09% to -$3.8 million in 2025.
  • Business Quant data shows Free Cash Flow for ICU at -$3.8 million in Q3 2025, -$3.0 million in Q2 2025, and -$2.7 million in Q1 2025.